ES496859A0 - Un procedimiento para preparar derivados de halofenil-piri- dilalilamina - Google Patents

Un procedimiento para preparar derivados de halofenil-piri- dilalilamina

Info

Publication number
ES496859A0
ES496859A0 ES496859A ES496859A ES496859A0 ES 496859 A0 ES496859 A0 ES 496859A0 ES 496859 A ES496859 A ES 496859A ES 496859 A ES496859 A ES 496859A ES 496859 A0 ES496859 A0 ES 496859A0
Authority
ES
Spain
Prior art keywords
halofenyl
dilalylamine
piri
derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES496859A
Other languages
English (en)
Other versions
ES8204721A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of ES8204721A1 publication Critical patent/ES8204721A1/es
Publication of ES496859A0 publication Critical patent/ES496859A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/48Aldehydo radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES496859A 1979-11-16 1980-11-14 Un procedimiento para preparar derivados de halofenil-piri- dilalilamina Granted ES496859A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7909514A SE7909514L (sv) 1979-11-16 1979-11-16 Nya halofenyl-pyridyl-allylaminderivat

Publications (2)

Publication Number Publication Date
ES8204721A1 ES8204721A1 (es) 1982-05-01
ES496859A0 true ES496859A0 (es) 1982-05-01

Family

ID=20339337

Family Applications (5)

Application Number Title Priority Date Filing Date
ES496859A Granted ES496859A0 (es) 1979-11-16 1980-11-14 Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES508063A Granted ES508063A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508064A Expired ES8300096A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508062A Granted ES508062A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508065A Granted ES508065A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES508063A Granted ES508063A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508064A Expired ES8300096A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508062A Granted ES508062A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508065A Granted ES508065A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Country Status (17)

Country Link
US (1) US4418065A (es)
EP (2) EP0029420A1 (es)
JP (1) JPS56501524A (es)
AU (1) AU538087B2 (es)
CA (1) CA1155128A (es)
DK (1) DK300781A (es)
ES (5) ES496859A0 (es)
FI (1) FI812196L (es)
GR (1) GR72129B (es)
NO (1) NO812401L (es)
NZ (1) NZ195558A (es)
PL (3) PL128457B1 (es)
PT (1) PT72066B (es)
SE (1) SE7909514L (es)
SU (4) SU1103794A3 (es)
WO (1) WO1981001407A1 (es)
ZA (1) ZA807102B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1150269A (en) * 1980-11-14 1983-07-19 Carl B. J. Ulff Process for preparing 3-(4-bromophenyl)-3-(3-pyridyl)-allylamines
US4610995A (en) * 1984-07-27 1986-09-09 Coker Geoffrey G Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties
GB8814639D0 (en) * 1988-06-20 1988-07-27 Ici Plc Heterocyclic tertiary alcohol derivatives
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6800652B2 (en) 2002-08-16 2004-10-05 Pfizer Inc. Diaryl compounds
GB0219154D0 (en) * 2002-08-16 2002-09-25 Pfizer Ltd Diaryl compounds
PT3066091T (pt) 2013-11-05 2019-07-11 Astrazeneca Ab Pro-farmacos de antagonista de nmda

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676964A (en) * 1950-06-07 1954-04-27 Schering Corp 3-pyridyl propylamine antihistamine substances
DE966534C (de) 1951-03-22 1957-08-22 Schering Corp Verfahren zur Herstellung von basisch substituierten Pyridinverbindungen
GB850298A (en) 1956-10-30 1960-10-05 Maggioni & C Societa Per Azion ª‡,ª‡[(p-chlorophenyl)-(4-pyridyl)] carbinols and method of preparing same
DE1468359A1 (de) * 1963-10-23 1968-11-28 Merck & Co Inc Verfahren zur Herstellung von Dibenzocycloheptehderivaten
US3396224A (en) * 1965-09-09 1968-08-06 Lilly Co Eli Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives
US3423510A (en) * 1966-08-31 1969-01-21 Geigy Chem Corp 3-(p-halophenyl) - 3 - (2'-pyridyl-n-methylpropylamine for the treatment of depression
US3471505A (en) * 1967-02-01 1969-10-07 Ciba Geigy Corp 1-(alkoxyphenyl)-1-(3-pyridyl)-carbinols
SE361663B (es) * 1971-04-28 1973-11-12 Haessle Ab
US3928369A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents, and a process for their preparation
US3928613A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents
SE373850B (es) * 1972-11-16 1975-02-17 Haessle Ab
US4094908A (en) * 1973-08-15 1978-06-13 Richter Gedeon Vegyeszeti Gyar Rt. Alpha-substituted benzhydrol derivatives
GB1480593A (en) * 1973-11-30 1977-07-20 Kefalas As Xanthene and thioxanthene derivatives having pharmaceutical activity
US4186202A (en) * 1974-11-21 1980-01-29 Astra Lakemedel Aktiebolag Phenyl-pyridylamine derivatives
US4102887A (en) * 1974-11-21 1978-07-25 Per Arvid Emil Carlsson Intermediates used in the preparation of phenyl-pyridylamine derivatives
SE388854B (sv) * 1974-11-21 1979-03-26 Astra Laekemedel Ab Forfarande for framstellning av fenylpyridylaminderivat
SE418291B (sv) * 1976-05-17 1981-05-18 Astra Laekemedel Ab 4-bromfenyl-3-pyridylderivat som mellanprodukter vid framstellning av fenylpyridylaminer
SE418399B (sv) * 1976-05-21 1981-05-25 Astra Laekemedel Ab Forfarande for framstellning av n,n-dimetyl-3-(4 bromfenyl)-3-(3-pyridyl)allylamin
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
IE47628B1 (en) * 1977-07-04 1984-05-16 Astra Laekemedel Ab Substituted aralkyl amines and amino-aryl alkenes having therapeutic activity
SE409861B (sv) * 1977-07-04 1979-09-10 Astra Laekemedel Ab Ett nytt forfarande for framstellning av en terapeutisk aktiv pyridinforening
SE409860B (sv) * 1977-07-04 1979-09-10 Astra Laekemedel Ab En ny mellanprodukt for framstellning av terapeutiskt aktiva pyridinforeningar

Also Published As

Publication number Publication date
US4418065A (en) 1983-11-29
DK300781A (da) 1981-07-07
GR72129B (es) 1983-09-16
ES8204721A1 (es) 1982-05-01
CA1155128A (en) 1983-10-11
SE7909514L (sv) 1981-05-17
PL232732A1 (es) 1982-08-16
ZA807102B (en) 1981-07-29
ES508064A0 (es) 1982-10-01
WO1981001407A1 (en) 1981-05-28
ES8300097A1 (es) 1982-10-01
NO812401L (no) 1981-07-13
NZ195558A (en) 1984-07-06
ES508065A0 (es) 1982-10-01
PL129370B1 (en) 1984-05-31
SU1138021A3 (ru) 1985-01-30
ES8300095A1 (es) 1982-10-01
ES508063A0 (es) 1982-10-01
ES8300096A1 (es) 1982-10-01
EP0029420A1 (en) 1981-05-27
EP0081478A3 (en) 1984-01-04
PT72066B (en) 1982-09-02
PL227849A1 (es) 1981-12-23
SU1149875A3 (ru) 1985-04-07
PL232731A1 (es) 1982-08-16
ES8300094A1 (es) 1982-10-01
PL128457B1 (en) 1984-01-31
FI812196L (fi) 1981-07-10
SU1149874A3 (en) 1985-04-07
SU1103794A3 (ru) 1984-07-15
PL129369B1 (en) 1984-05-31
PT72066A (en) 1980-12-01
ES508062A0 (es) 1982-10-01
AU538087B2 (en) 1984-07-26
JPS56501524A (es) 1981-10-22
AU6437880A (en) 1981-05-21
EP0081478A2 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
ES496948A0 (es) Un procedimiento para preparar compuestos de cefem
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
ES489222A0 (es) Un procedimiento para preparar un compuesto de guanidinotia-zol
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES493061A0 (es) Un procedimiento para preparar un lipopolisacarido
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
ES490292A0 (es) Un procedimiento para preparar derivados de 2-imidazolina
ES489729A0 (es) Un procedimiento para preparar derivados de oxapenem
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
ES497301A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES493498A0 (es) Un procedimiento para preparar derivados de metilencicloami-na
ES494459A0 (es) Un procedimiento para preparar cetoximinoeteres
ES496859A0 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES505496A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
ES488234A0 (es) Un procedimiento para preparar un derivado de cefema
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES488808A0 (es) Un procedimiento para preparar derivados de fenotiazina
ES498146A0 (es) Un procedimiento para preparar derivados de 2,2-dicloroace- tamida
ES492692A0 (es) Procedimiento para preparar derivados de benoimidazol
AR224652A1 (es) Un procedimiento para preparar derivados de decahidroquinolinol
ES498168A0 (es) Un procedimiento para preparar alcohilfosfonoditioato de al-cohilo